Summary & Overview
HCPCS Q9951: Low Osmolar High-Iodine Contrast Material, per ml
HCPCS Level II code Q9951 represents a high-concentration, low osmolar iodinated contrast material (400 mg/ml or greater) billed per milliliter for use in diagnostic imaging. Nationally, precise coding for contrast agents affects billing accuracy, inventory management, and aggregate imaging costs across payers. Accurate use of Q9951 ensures clinical documentation aligns with product selection and supports consistent reimbursement practices for high-iodine formulations.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for high-iodine contrast use, typical sites of service where Q9951 is applied, and the practical implications for billing teams. The publication highlights common modifiers associated with contrast administration and notes where input data is not available.
This summary equips billing managers, radiology administrators, and policy analysts with the core facts needed to reconcile coding policies, understand payer coverage scope, and prepare for reimbursement review or audits. Data not available in the input is clearly identified where applicable.
Billing Code Overview
HCPCS Level II code Q9951 denotes low osmolar contrast material with an iodine concentration of 400 mg/ml or greater, billed per milliliter. This product is used as an intravascular radiographic contrast agent to enhance imaging contrast in diagnostic radiology procedures.
Service type: Contrast agent for diagnostic imaging
Typical site of service: Imaging suites and hospital radiology departments, including outpatient imaging centers and inpatient radiology services.
Clinical & Coding Specifications
Clinical Context
A patient presenting for a contrast-enhanced imaging study receives low osmolar iodinated contrast material Q9951 (≥400 mg iodine per ml). Typical patients are adults undergoing diagnostic computed tomography (CT) of the head, neck, chest, abdomen, pelvis, or CT angiography where high-iodine concentration is required for vascular opacification or lesion characterization. The clinical workflow: patient arrives at the imaging center or hospital radiology department, screening for contrast allergies and renal function (serum creatinine/eGFR) is performed; IV access is established (often power-injectable peripheral IV or central access for oncology patients); the technologist prepares and documents the amount and concentration of Q9951 administered; the radiologist or ordering clinician verifies the indication (e.g., suspected pulmonary embolism, oncologic staging, abdominal pain with suspected vascular injury); contrast is power-injected per protocol during CT acquisition; post-procedure monitoring for immediate contrast reactions occurs; contrast usage and lot/volume are documented in the imaging report and charge capture. Typical site of service: hospital outpatient radiology, outpatient imaging center, emergency department, or inpatient radiology. Typical patient scenario: an adult with acute flank pain and hematuria undergoing CT angiography to evaluate for renal artery stenosis or suspected vascular injury who requires a high-iodine concentration low-osmolar contrast agent for optimal vascular opacification.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|